No­var­tis re­sumes re­mote busi­ness in Ukraine af­ter safe­ty pro­to­col re­view

Months af­ter a slate of phar­ma com­pa­nies slammed the brakes on some op­er­a­tions in both Rus­sia and Ukraine, No­var­tis an­nounced that it’s re­sum­ing busi­ness re­mote­ly in Ukraine “to help the war-torn coun­try re­store some ba­sic crit­i­cal busi­ness process­es.”

No­var­tis came to the de­ci­sion af­ter study­ing safe­ty pro­to­cols and re­ceiv­ing ad­vice “which we will reg­u­lar­ly re­view,” the com­pa­ny said on Wednes­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.